Authorised establishments or organisations shall make available to the Agence nationale de sécurité du médicament et des produits de santé updated data concerning staff, equipment and any information necessary for the evaluation of all the activities for which they are authorised, including those provided for in Article R. 1243-3-1. They draw up and keep up to date a list of the agreements they have entered into with third parties whose involvement has an influence on the quality and safety of tissues or their derivatives or cell therapy preparations. This list and these agreements are made available to the Agence nationale de sécurité du médicament et des produits de santé and to the persons responsible for carrying out inspections, in accordance with the provisions of Article R. 5313-6-3.